Biological markers and schizophrenia
- 1 November 2000
- journal article
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 34 ((Suppl.)) , S108-S112
- https://doi.org/10.1046/j.1440-1614.2000.00778.x
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Thought disorder in adolescent-onset schizophreniaSchizophrenia Research, 1997
- Psychobiologic correlates of treatment response in schizophreniaNeuropsychopharmacology, 1996
- A missense mutation in the neuronal nicotinic acetylcholine receptor α4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsyNature Genetics, 1995
- Cerebral ventricle dimensions as risk factors for schizophrenia and affective psychosis: an epidemiological approach to analysisPsychological Medicine, 1994
- A Meta-Analysis of Homovanillic Acid Concentrations in SchizophreniaInternational Journal of Neuroscience, 1993
- Analysis of cerebrospinal fluid monoamines in schizophrenic patients on and off neuroleptic treatment and compared with healthy controlsSchizophrenia Research, 1991
- The ventricle-brain ratio (VBR) in functional psychoses: An admixture analysisPsychiatry Research: Neuroimaging, 1990
- Anatomical Abnormalities in the Brains of Monozygotic Twins Discordant for SchizophreniaNew England Journal of Medicine, 1990
- Prolactin response to low-dose haloperidol challenge in schizophrenic, non-schizophrenic psychotic, and control subjectsPsychoneuroendocrinology, 1990
- DOPAMINE D2 RECEPTORS IN SCHIZOPHRENIA STUDIED IN VIVOThe Lancet, 1986